Position
Head of Research and Development
Company
Jade Biosciences
WalthamInformation TechnologyBiotechnologyHealthcareHealth CareTherapeuticsDescription
Jade Biosciences, Inc. announced the closing of an $80 million financing led by Fairmount and Venrock Healthcare Capital Partners. The company appointed Andrew King, D.V.M., Ph.D., with over 15 years of leadership experience, as the Chief Scientific Officer.
Quick answer
Jade Biosciences Names Andrew King as Chief Scientific Officer (August 1, 2024). Jade Biosciences is based in Waltham, Massachusetts, United States.
- Who is the new Head of Research and Development at Jade Biosciences?
- Jade Biosciences named Andrew King Head of Research and Development, announced August 1, 2024.
- What did Jade Biosciences announce on August 1, 2024?
- Jade Biosciences, Inc. announced the closing of an $80 million financing led by Fairmount and Venrock Healthcare Capital Partners. The company appointed Andrew King, D.V.M., Ph.D., with over 15 years of leadership experience, as the Chief Scientific Officer.
- What does Jade Biosciences do?
- Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases.
- Where is Jade Biosciences based?
- Jade Biosciences is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (July 10, 2024), MBX Biosciences, Inc. (June 25, 2024), NYU Langone Health (July 25, 2024) and Engrail Therapeutics (August 8, 2024) also announced leadership changes within 45 days of Jade Biosciences.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Appoints Roopal Thakkar, M.D. as Executive Vice President, R&D and Chief Scientific Officer (July 10, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
- NYU Langone Health's Perlmutter Cancer Center Names Jonathan M. Gerber, MD, as Chief Clinical Officer (July 25, 2024)
- Engrail Therapeutics Appoints Paul Cayer as Chief Financial Officer (August 8, 2024)
- Intra-Cellular Therapies Appoints Sanjeev Narula as Executive Vice President, Chief Financial Officer (August 8, 2024)
- Exicure, Inc. Appoints Anna Chukaeva as Senior Vice President, Head of Corporate Development and Bioinformatics (August 8, 2024)
Who to call at Jade Biosciences, and when
A new leader at Jade Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Jade Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jade Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jade Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jade Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Jade Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.